Literature DB >> 15291678

Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients.

Silvio Bellino1, Paola Rocca, Luca Patria, Livio Marchiaro, Roberta Rasetti, Rossella Di Lorenzo, Erika Paradiso, Filippo Bogetto.   

Abstract

BACKGROUND: A number of studies investigated the relationships of age at onset with clinical presentation and cognitive performance of schizophrenic patients. The aim of the present study was to assess demographic and clinical characteristics; psychopathologic, social functioning, and quality-of-life ratings; and neuropsychological measures in a sample of patients with stabilized schizophrenia and to identify which factors independently contributed to a multiple regression model with age at onset as the dependent variable.
METHOD: Ninety-six consecutive outpatients with schizophrenia (DSM-IV-TR criteria) were included in the study. Assessment instruments were as follows: a semistructured interview, the Clinical Global Impressions scale, the Comprehensive Psychopathological Rating Scale, and the Positive and Negative Syndrome Scale (PANSS) for psycho-pathology of schizophrenia; the Calgary Depression Scale for Schizophrenia (CDSS) for depression; the Social and Occupational Functioning Assessment Scale and the Sheehan Disability Scale for social functioning; the Quality of Life Scale; and a neuro-psychological battery including the Wisconsin Card Sorting Test (WCST) and the Continuous Performance Test. Two models of multiple regression were tested: the first included clinical features and psychopathologic, social functioning, and quality-of-life scales; the second also considered neuro-psychological variables. Data were collected from October 2001 to November 2002.
RESULTS: The first multiple regression showed that age at onset was significantly related to scores on the PANSS subscale for negative symptoms (p =.042) and the CDSS (p =.041); the second regression found a relation of age at onset with PANSS score for negative symptoms (p =.002) and 2 neuropsychological measures, number of preservative errors on the WCST and Continuous Performance Test reaction time (p =.0005 for both).
CONCLUSION: Our data indicate that, when results of neuropsychological tests are considered, early age at onset of schizophrenia is associated with severity of negative symptoms and compromised cognitive measures of executive functioning and sustained attention.

Entities:  

Mesh:

Year:  2004        PMID: 15291678     DOI: 10.4088/jcp.v65n0705

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Trajectories of social withdrawal and cognitive decline in the schizophrenia prodrome.

Authors:  Kathryn Cullen; Angela Guimaraes; Jeffrey Wozniak; Afshan Anjum; S Charles Schulz; Tonya White
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

2.  Functioning in middle aged and older patients with schizophrenia and depressive symptoms: relationship to psychopathology.

Authors:  John Kasckow; Thomas Patterson; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Somaia Mohamed; Sidney Zisook
Journal:  Am J Geriatr Psychiatry       Date:  2008-08       Impact factor: 4.105

3.  The course and outcomes of episodic endogenous psychoses with juvenile onset (a follow-up study).

Authors:  V G Kaleda
Journal:  Neurosci Behav Physiol       Date:  2009-11

4.  Joint analysis of cognitive and circadian variation in Schizophrenia and Bipolar I Disorder.

Authors:  Pramod Thomas; Fanyin He; Sati Mazumdar; Joel Wood; Triptish Bhatia; Ruben C Gur; Raquel E Gur; Daniel Buysse; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2017-11-07

5.  Age at onset and clinical correlates in body dysmorphic disorder.

Authors:  Andri S Bjornsson; Elizabeth R Didie; Jon E Grant; William Menard; Emily Stalker; Katharine A Phillips
Journal:  Compr Psychiatry       Date:  2013-04-30       Impact factor: 3.735

6.  Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia.

Authors:  Jane Pei-Chen Chang; Kuo-Hao Huang; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-20       Impact factor: 2.570

7.  Risk of First-Episode Schizophrenia in Aged Adults Increased During COVID-19 Outbreak.

Authors:  Wei Hu; Li Su; Deyong Li; Yi Zhou; Jing Zhu
Journal:  Int J Ment Health Addict       Date:  2021-10-12       Impact factor: 11.555

8.  Wisconsin Card Sorting Test scores and clinical and sociodemographic correlates in Schizophrenia: multiple logistic regression analysis.

Authors:  Masahiro Banno; Takayoshi Koide; Branko Aleksic; Takashi Okada; Tsutomu Kikuchi; Kunihiro Kohmura; Yasunori Adachi; Naoko Kawano; Tetsuya Iidaka; Norio Ozaki
Journal:  BMJ Open       Date:  2012-11-06       Impact factor: 2.692

9.  Can Psychological, Social and Demographical Factors Predict Clinical Characteristics Symptomatology of Bipolar Affective Disorder and Schizophrenia?

Authors:  Malgorzata Maciukiewicz; Joanna Pawlak; Pawel Kapelski; Magdalena Łabędzka; Maria Skibinska; Dorota Zaremba; Anna Leszczynska-Rodziewicz; Monika Dmitrzak-Weglarz; Joanna Hauser
Journal:  Psychiatr Q       Date:  2016-09

10.  Medication nonadherence among South American patients with schizophrenia.

Authors:  Alejandra Caqueo-Urízar; Alfonso Urzúa; Guillaume Fond; Laurent Boyer
Journal:  Patient Prefer Adherence       Date:  2017-10-06       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.